Studies have shown that multiple cells in TME play a significant role in tumor immunotherapy, including T cell, fibroblasts, natural killer (NK) cell, dendritic cells (DCs), and so on (7–9), NK cells stimulate cDC1 to enter into the TME and promote tumor immune control (10). This evidence concerns the gene MPPE1 and neoplasm.